COMP <GO>
FLGT vs YDES // REVENUE GROWTH (YOY)
Fulgent Genetics Inc. (NASDAQ) VS. YD Bio Limited (NASDAQ) • 15-METRIC TALLY: FLGT 6
— YDES 4
▲ REVENUE GROWTH (YOY) LEADER: YDES
LAST: $20.62 (-4.89%) • MKT CAP: $596.5M
revenue-growth
13.80%
LAST: $5.94 (+1.19%) • MKT CAP: $415.8M
revenue-growth
16.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLGT VS. YDES)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FLGT | YDES | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.60% | 28.10% | +12.50 | FLGT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.80% | -20.00% | +13.20 | FLGT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -20.82% | -1.93% | -18.89 | YDES | /fcf-yield <GO> |
| Operating Margin | -28.20% | -60.00% | +31.80 | FLGT | /operating-margins <GO> |
| Net Profit Margin | -18.80% | -60.00% | +41.20 | FLGT | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 13.80% | 16.90% | -3.10 | YDES | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.44 | 13.44 | -9.00 | YDES | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | YDES | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.3 | 51.7 | +4.60 | FLGT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $596.5M | $415.8M | $180.8M | FLGT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FLGT REV | YDES REV | FLGT GROSS % | YDES GROSS % | FLGT FCF | YDES FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $322.7M | $596.8K | 40.6% | 28.1% | -$124.2M | -$8.0M |
| FY 2024 | $283.5M | $510.4K | 37.8% | 30.4% | -$19.3M | -$1.3M |
| FY 2023 | $289.2M | $350.1K | — | — | $27.0M | -$55.7K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLGT // BETA —
YDES // BETA —